Company: LIMN
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001104659-25-006325
Chunk: 375

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-27
Form: POS AM
Chunk 375
---
 year ended December 31, 2022 due to the loans to the Iris entity.

Financing Activities

Net cash provided by financing activities for the nine months ended September 30, 2024 of $3.2 million resulted from borrowings from Valetudo, Prophase and Hana of $0.8 million, $1.6 million and $0.8 million, respectively. Net cash used in financing activities of $1.7 million for the nine months ended September 30, 2023 was from $2.0 million from borrowings with Valetudo, offset by $3.7 million of repayments for two short-term loans.

Net cash used in financing activities for the year ended December 31, 2023 of $0.5 million resulted from loan payments made on the Ewon Loan and Prophase Loans of $3.9 million offset by $3.4 million received in short-term loans from Valetudo and Ewon. Net cash provided by financing activities for the year ended December 31, 2022 of $5.9 million was primarily due to $4.2 million received from Ewon’s membership purchase and proceeds of short-term debt borrowings of $7.1 million; offset by $3.3 million of repayment of the loan from TDT, $1.4 million of repayments for two related party short-term loans, and $0.7 million from repurchasing Class A member units.

#### Contractual Obligations and Other Commitments
As of September 30, 2024, we have contractual obligations related to the Feelux Bonds of $10.0 million issued in 2018, and related interest of 1% per annum compounded annually which is expected to be settled through the issuance of ParentCo common shares upon the closing of the Business Combination, our non-interest bearing loan from Car-Tcellkor of $0.8 million due in May 2023, our non-interest bearing Valetudo Loan of $0.7 million, issued in December 2022 which was due in June 2023, the $2.0 million Ewon Loan issued in December 2022, which was due in December 2023, and related interest of 2% per annum, the Valetudo June 2023 Loans totaling $0.5 million, which are non-interest bearing and were due in December 2023, our Valetudo July 2023 Loan of $0.3 million issued in July